CLB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Core Laboratories Inc (CLB) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock's technical indicators are weak, there are no significant trading signals, and financial performance shows mixed results. While the gross margin has improved, net income and EPS have declined. Additionally, there are no recent positive news catalysts or significant trading trends to suggest an immediate opportunity.
The MACD is negative and expanding (-0.228), indicating bearish momentum. RSI is neutral at 32.152, and moving averages are converging, suggesting no clear trend. Key support is at 17.518, and resistance is at 19.864. The stock is trading near its support level, but there is no strong indication of a reversal.
Gross margin increased by 20.95% YoY in Q4 2025, indicating improved operational efficiency.
No recent news or significant trading trends from hedge funds or insiders. The stock has a 50% probability of only modest gains (0.66% in the next day, 1.93% in the next week).
In Q4 2025, revenue increased by 6.98% YoY to $138.26M, but net income dropped to $7.08M (-4.34% YoY), and EPS fell to $0.15 (-6.25% YoY). Gross margin improved to 18.13% (+20.95% YoY).
No recent updates on analyst ratings or price targets.
